B. Potter

发表

The effects of 2-methoxy oestrogens and their sulphamoylated derivatives in conjunction with TNF-α on endothelial and fibroblast cell growth, morphology and apoptosis

A. Purohit, M. Reed, S. Newman, 2003, The Journal of Steroid Biochemistry and Molecular Biology.

Inhibition of steroid sulphatase activity by steroidal methylthiophosphonates: Potential therapeutic agents in breast cancer

B. Potter, N. Howarth, A. Purohit, 1994, The Journal of Steroid Biochemistry and Molecular Biology.

The regulation and inhibition of 17β-hydroxysteroid dehydrogenase in breast cancer

H. Tutill, J. Day, A. Purohit, 2006, Molecular and Cellular Endocrinology.

Steroid sulphatase inhibitors for breast cancer therapy

B. Potter, A. Purohit, M. Reed, 2003, The Journal of Steroid Biochemistry and Molecular Biology.

The nature of inhibition of steroid sulphatase activity by tibolone and its metabolites

B. Potter, J. Day, A. Purohit, 2005, The Journal of Steroid Biochemistry and Molecular Biology.

The effects of 2-methoxyoestrogen sulphamates on the in vitro and in vivo proliferation of breast cancer cells

A. Purohit, M. Reed, S. Newman, 2005, The Journal of Steroid Biochemistry and Molecular Biology.

Regulation of aromatase activity by cytokines, PGE2 and 2-methoxyoestrone-3-O-sulphamate in fibroblasts derived from normal and malignant breast tissues

B. Potter, A. Purohit, M. Reed, 2005, The Journal of Steroid Biochemistry and Molecular Biology.

Regulation of steroid sulphatase expression and activity in breast cancer

A. Purohit, M. Reed, S. Newman, 2000, The Journal of Steroid Biochemistry and Molecular Biology.

Measurement of oestrone sulphatase activity in white blood cells to monitor in vivo inhibition of steroid sulphatase activity by oestrone-3-O-sulphamate

B. Potter, A. Purohit, M. Reed, 1997, The Journal of Steroid Biochemistry and Molecular Biology.

In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone‐3‐O‐sulphamate

B. Potter, A. Purohit, M. Reed, 1995, International journal of cancer.

Growth inhibition of multi-drug-resistant breast cancer cells by 2-methoxyoestradiol-bis-sulphamate and 2-ethyloestradiol-bis-sulphamate

A. Purohit, M. Reed, S. Newman, 2003, The Journal of Steroid Biochemistry and Molecular Biology.

Inhibition of deoxyglucose uptake in MCF-7 breast cancer cells by 2-methoxyestrone and 2-methoxyestrone-3-O-sulfamate

A. Purohit, M. Reed, A. Singh, 2000, Molecular and Cellular Endocrinology.

Regulation and Inhibition of Steroid Sulfatase Activity in Breast Cancer a

B. Potter, A. Purohit, M. Reed, 1996, Annals of the New York Academy of Sciences.

Human granulosa cells are a site of sulphatase activity and are able to utilize dehydroepiandrosterone sulphate as a precursor for oestradiol production.

B. Potter, H. Mason, A. Purohit, 2000, The Journal of endocrinology.

The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers

B. Potter, J. Day, A. Purohit, 2007, British Journal of Cancer.

BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure

H. Tutill, B. Potter, J. Day, 2009, British Journal of Cancer.

Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents

B. Potter, A. Purohit, M. Reed, 2004, British Journal of Cancer.

Pharmacokinetics of the nonsteroidal steroid sulphatase inhibitor 667 COUMATE and its sequestration into red blood cells in rats

B. Potter, A. Purohit, M. Reed, 2004, British Journal of Cancer.

2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer

B. Potter, A. Purohit, M. Reed, 2008, British Journal of Cancer.